跳至主要内容
临床试验/NCT05810324
NCT05810324招募中不适用

The Performance of 18F-FAPI PET/CT in Patients With Various Types of Cancer

Jilin University1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2022年7月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
500
试验地点
1
主要终点
Diagnostic accuracy

研究概览

简要总结

To evaluate the potential usefulness of 18F-FAPI positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various types of cancer.

详细描述

Subjects with various types of cancer underwent 18F-FAPI PET/CT either for an initial assessment or for recurrence detection. Tumor uptake was quantified by the maximum standard uptake value (SUVmax). Using histopathology and follow-up as gold standard, the sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and accuracy of 18F-FAPI PET/CT were calculated.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients with suspected or new diagnosed or previously treated malignant tumors (supporting evidence may include MRI, CT, tumor markers and pathology report);
  • patients who had scheduled 18F-FAPI PET/CT scan; (iv)
  • patients who were able to provide informed consent (signed by participant, parent or legal representative) and assent according to the guidelines of the Clinical Research Ethics Committee.

排除标准

  • patients with non-malignant lesions;
  • patients with pregnancy;
  • the inability or unwillingness of the research participant, parent or legal representative to provide written informed consent.

研究组 & 干预措施

18F-FAPI

Experimental

Experimental: Experimental: 18F-FAPI Each subject receive a single intravenous injection of 18F-FAPI, and undergo PET/CT imaging within the specificed time.

干预措施: 18F-FAPI (Drug)

结局指标

主要结局

Diagnostic accuracy

时间窗: 1 year

The sensitivity, specificity and accuracy of 18F-FAPI PET/CT were calculated.

次要结局

未报告次要终点

研究者

发起方
Jilin University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ji Bin

Doctor

Jilin University

研究点 (1)

Loading locations...

相似试验